| 11/26/2024 | HY | New Issue: Grunenthal sells €500 million 4 5/8% seven-year secured notes at par
|
| 11/26/2024 | HY | Grunenthal talks €500 million secured notes due 2031 at 4¾% area; books close Tuesday
|
| 11/25/2024 | HY | Market Commentary: Blackstone prices; euro-denominated primary hot; EchoStar notes heavily traded
|
| 11/25/2024 | BKHY | Moody’s rates Grunenthal notes B1
|
| 11/25/2024 | BKHY | S&P rates Grunenthahl notes BB-
|
| 11/25/2024 | HY | Grunenthal Pharma to sell €500 million seven-year secured notes
|
| 4/5/2024 | BKHY | Moody’s moves Grunenthal view to stable
|
| 4/19/2023 | HY | Market Commentary: Junk: Navacord prices add-on; Clarios on deck; CSC Holdings weaker; loanDepot catapults
|
| 4/19/2023 | HY | New Issue: Grunenthal prices €300 million 6¾% seven-year secured notes at par
|
| 4/17/2023 | HY | Market Commentary: Lindblad drives-by; Kedrion on deck; Cengage jumps on private investment; Cleveland-Cliffs falls
|
| 4/17/2023 | BKHY | Moody’s rates Grunenthal notes B1
|
| 4/17/2023 | HY | Grunenthal starts roadshow for €300 million seven-year secured notes
|
| 4/17/2023 | BKHY | Fitch gives Grunenthal note BB+
|
| 4/14/2022 | BKHY | Moody's views Grunenthal positively
|
| 7/6/2021 | HY | New Issue: Grunenthal prices €300 million tap of 4 1/8% notes due 2028 at 102
|
| 4/27/2021 | HY | New Issue: Grunenthal prices upsized, revised €650 million notes in two tranches
|
| 4/22/2021 | HY | Grunenthal launches upsized, revised €650 million two-part notes offering tighter than talk
|
| 4/21/2021 | HY | Grunenthal upsizes notes offering to €650 million, adds €250 million seven-year tranche
|
| 4/20/2021 | HY | Germany’s Grunenthal marketing €500 million 5.5-year secured notes through Wednesday
|
| 4/19/2021 | BKHY | Fitch assigns Grunenthal BB, notes BB+
|
| 4/19/2021 | BKHY | Moody's assigns Grunenthal, notes B1
|
